Goodbye Colonoscopy? New Stool Test Detects Cancer Early 

A Simpler Way to Screen for Cancer 

Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. When detected early, it can often be treated successfully. However, the current screening method, colonoscopy, is expensive and uncomfortable for many people. Because of this, a large number of individuals delay or avoid testing, which increases the risk of late diagnosis. 

New Research Using Gut Bacteria 

Researchers at the University of Geneva have introduced a new technique that could change this situation. By using machine learning, they created a detailed catalogue of human gut bacteria. This catalogue identifies bacteria at a subspecies level, allowing scientists to understand how different microbial groups function in the body. 

According to Towards Healthcare, the colorectal cancer diagnostics market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 20.36 billion in 2026 to approximately USD 43.87 billion by 2035, representing a compound annual growth rate (CAGR) of 8.9% from 2026 to 2035. Rising demand for early detection, growing awareness, technological advances in non-invasive testing, expanding healthcare access, and increasing global cancer burden are creating strong opportunities in the colorectal cancer diagnostics market. 

Why Subspecies Matter 

Scientists have long known that gut bacteria are linked to colorectal cancer. However, studying them has been challenging because bacteria within the same species can behave very differently. Some may promote cancer, while others do not. Focusing on subspecies provides a balanced approach, capturing important differences while still being useful across populations. 

Promising Results from Stool Testing 

Using this method, researchers developed a model that can detect colorectal cancer through simple stool samples. The test successfully identified around ninety percent of cancer cases, which is close to the detection rate of colonoscopy. It also performed better than existing non-invasive tests. 

With more clinical data, the accuracy of this method could improve further. In the future, such tests could be used for routine screening, while colonoscopies may be reserved for confirming positive results. 

Future Possibilities Beyond Cancer 

Researchers are now planning clinical trials to better understand how well this method works at different stages of the disease. The approach could also help scientists explore how gut bacteria affect other health conditions. In the long term, this simple stool test may lead to easier and more affordable diagnosis for many diseases. 

This innovation highlights the growing role of artificial intelligence in medicine. By making testing simpler and more accessible, it could encourage more people to get screened early and save lives worldwide in the years ahead. 

A recent report by Towards Healthcare highlights that the colorectal cancer diagnostics market is witnessing growth due to increasing screening initiatives, improved diagnostic technologies, rising healthcare investments, and a growing focus on preventive care worldwide.